Portfolio

AXT enhances cellular research product portfolio with solutions from StemBioSys

AXT is pleased to announce it has further enhanced its cellular research product portfolio through the addition of stem cell solutions from StemBioSys. The recently signed agreement will see AXT...

Read more
CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)

SAN FRANCISCO--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24NVTA&src=ctag" target="_blank">$NVTA</a> <a href="https://twitter.com/hashtag/diagnostics?src=hash" target="_blank">#diagnostics</a>--In the headline, and in the first sentence of the release, “(NASDAQ: NVTA)” should instead read “(NYSE: NVTA)” The corrected release reads: CIVILIZATION...

Read more
New Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio

[ad_1] SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data for its approved and investigational medicines for the...

Read more
Dr. Reddy’s Laboratories Announces Acquisition of ANDA Portfolio

[ad_1] HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announced today that it...

Read more
Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio

Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend for its guidance on all matters occuring after a drug…...

Read more
Blockchain platform Healthereum Life Portfolio incentivizes appointment adherence with tokens

[ad_1] The new platform gives patients tokens for showing up to appointments, answering surveys and completing other health-related activities.  Source link [ad_2]

Read more
Lonza expands portfolio with addition of new 'Verified for Spheroids Human Hepatocytes'

[ad_1] Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in...

Read more
Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio

[ad_1] HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio Source link [ad_2]

Read more
Global Mouthwash Market 2019-2023| Innovation and Portfolio Expansion Impacting Market Growth| Technavio

[ad_1] LONDON--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/HealthandWellness?src=hash" target="_blank"gt;#HealthandWellnesslt;/agt;--The global mouthwash market 2019-2023 is expected to post a CAGR of close to 6% during the forecast period, according to Technavio. Source link [ad_2]

Read more
CeraVe Expands Skincare Portfolio with New Products

[ad_1] CeraVe, a skincare brand owned by L’Oréal, introduces four new therapeutic skincare products: a Hydrating Hyaluronic Acid Serum and a Diabetics’ Dry Skin Relief line, which includes a Moisturizing...

Read more
Halyard Introduces Latest in HALYARD* CHEMO GEAR* Portfolio Designed to Protect Healthcare Workers from Cytotoxic Drugs

[ad_1] Halyard, a leading global provider of solutions for the prevention of healthcare-associated infections across acute care and non-acute care settings, today introduced the latest additions to its CHEMO GEAR*...

Read more
Pharmaceutical Portfolio Management Reading List

This article was originally published at https://www.drugpatentwatch.com/blog/pharmaceutical-portfolio-management-reading-list/ Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries This book describes the way that pharmaceutical projects and programs are currently...

Read more
RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North...

Read more
Amicus Therapeutics acquires portfolio of gene therapies targeting neurologic disorders

Amicus Therapeutics is expanding the focus its drug development work with the purchase of a portfolio of early-stage gene therapies targeting rare neurologic diseases, the company announced Thursday. Two of...

Read more
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the CE marking and launch of the...

Read more
SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived from Mesenchymal Stem Cells

TOKYO--(BUSINESS WIRE)--The SanBio Group, a scientific leader in regenerative medicine for neurological disorders, today announced the acquisition of a patent portfolio regarding cell medicines derived from mesenchymal stem cells (hereinafter...

Read more
Portfolio diet lowers many risk factors for heart disease

University of Toronto researchers have found that the portfolio diet, a plant-based way of eating previously shown to lower cholesterol levels, reduces other risk factors for cardiovascular disease including blood...

Read more